---
layout: page
title: MPEP Patent Appilcation Manual
image:
  feature: /wide/transmission-patent-gray-blueprint.jpg
---
   <head>
      <title>1895-</title>
      <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
</head>
      <li><a href="index.html">Manual of Patent Examining Procedure</a></li>
      <li><a href="mpep-1800.html"><span>Chapter 1800</span></a></li>
      <li><span>Section 1895</span></li>  </ul>
      <div id="yui-main">
         <div class="yui-b">
            <div class="yui-g">  <div xmlns:bf="http://www.uspto.gov/bf" id="article">
               <div>
                  <div xmlns="" class="Section" id="d0e192715">
                     <h1 class="page-title">1895
                          
                         A Continuation , Divisional, or Continuation- in- Part
                        			Application of a PCT Application Designating the United States  [R-08.2012]
                     </h1>
                     <p id="d0e192727"> It is possible to file a U.S.
                        			national application under <b><a href="mpep-9015-appx-l.html#d0e302673">35 U.S.C. 111(a)</a></b> during the
                        			pendency (prior to the abandonment) of an international application which designates the
                        			United States without completing the requirements for entering the national stage under
                        				<b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C. 371(c)</a></b> . The ability to take such action is based on
                        			provisions of the United States patent law. <b><a href="mpep-9015-appx-l.html#d0e306994">35 U.S.C. 363</a></b>
                        			provides that “[a]n international application designating the United States shall have
                        			the effect, from its international filing date under article 11 of the treaty, of a
                        			national application for patent regularly filed in the Patent and Trademark Office....”
                        				<b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C. 371(d)</a></b> indicates that failure to timely comply with
                        			the requirements of <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C. 371(c)</a></b> “shall be regarded
                        			as abandonment... by the parties thereof....” It is therefore clear that an
                        			international application which designates the United States has the effect of a pending
                        			U.S. application from the international application filing date until its abandonment as
                        			to the United States. The first sentence of <b><a href="mpep-9015-appx-l.html#d0e307034">35 U.S.C. 365(c)</a></b>
                        			specifically provides that “[i]n accordance with the conditions and requirements of
                        			section 120 of this title,... a national application shall be entitled to the benefit of
                        			the filing date of a prior international application designating the United States.” The
                        			condition of <b><a href="mpep-0010-title-page.html#d0e303023">35 U.S.C. 120</a></b> relating to the time
                        			of filing requires the later application to be filed before the patenting or abandonment
                        			of or termination of proceedings on the first application. The filing of continuations
                        			of an international (PCT) application designating the U.S. was used primarily in
                        			instances where there was difficulty in obtaining a signed oath or declaration by the
                        			expiration of the time for entry into the national stage. Because these continuation
                        			applications historically resulted from a need to bypass the requirements of 35 U.S.C.
                        				<b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> , they became known as “bypass” applications. Since
                        			applicants are now notified of missing or defective oaths or declarations and/or
                        			translations, and are given a time period to respond which is extendable under
                        				<b><a href="mpep-9020-appx-r.html#d0e323655">37 CFR 1.136(a)</a></b> , the use of this practice with respect to
                        			continuation applications has diminished. 
                     </p>
                     <p id="d0e192765"> Continuation-in-part applications
                        			are generally filed in instances where applicants seek to add matter to the disclosure
                        			which is not supported by the disclosure of the international application as originally
                        			filed, as new matter may not be added to a U.S. national stage application. See 37 CFR
                        				<b><a href="mpep-9020-appx-r.html#d0e323020">1.121</a></b> (f). 
                     </p>
                     <div class="Section">
                        <h1 class="page-title" id="d0e192774">1895.01
                             Handling of and Considerations in the Handling of
                           				Continuations, Divisions, and Continuations-In-Part of PCT Applications [R-08.2012]
                        </h1>
                        <p id="d0e192790"> Rather than submitting national
                           				stage application papers under <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C. 371</a></b> , a continuing
                           				application (i.e., continuation, C-I-P, or division) under <b><a href="mpep-9015-appx-l.html#d0e302673">35 U.S.C.
                                 					111(a)</a></b> of the international (PCT) application may be filed.
                           				Pursuant to <b><a href="mpep-9015-appx-l.html#d0e307034">35 U.S.C. 365(c)</a></b> , a regular
                           				national application filed under <b><a href="mpep-9015-appx-l.html#d0e302673">35 U.S.C.
                                 					111(a)</a></b> and <b><a href="mpep-9020-appx-r.html#d0e318681">37 CFR 1.53(b)</a></b>
                           				(not under <b><a href="mpep-9020-appx-r.html#d0e318681">37 CFR 1.53(d)</a></b> ) may claim
                           				benefit of the filing date of an international application which designates the
                           				United States. 
                        </p>
                        <p id="d0e192811">A typical time line involving a
                           				continuing application filed during the pendency of an international application is
                           				illustrated as follows:
                        </p>
                        <div class="figure" id="d0e192814"><img src="graphics/1895_01-1.png" alt="Illustration of a typical time line involving a continuing application filed during pendency of an international application." width="416" height="224"></div>
                        <p id="d0e192817"> To obtain benefit under 35
                           				U.S.C. <b><a href="mpep-0010-title-page.html#d0e303023">120</a></b> and <b><a href="mpep-9015-appx-l.html#d0e307034">365</a></b> (c) of a prior international application designating the
                           				U.S., the continuing application must: 
                        </p>
                        <div id="d0e192826" class="List">
                           <ul style="list-style-type: none;">
                              <li id="d0e192827" class="nobull">(A)  include a specific
                                 							reference to the prior international application (either in the
                                 							application data sheet (37 CFR <b><a href="mpep-9020-appx-r.html#d0e320348">1.76</a></b> ) or in the first sentence(s) of the
                                 							specification), 
                              </li>
                              <li id="d0e192834" class="nobull">(B) be copending with the
                                 							prior international application, and
                              </li>
                              <li id="d0e192838" class="nobull">(C) have at least one
                                 							inventor in common with the prior international
                                 							application.
                              </li>
                           </ul>
                        </div>
                        <p id="d0e192842"> With regard to (A), the specific
                           				reference to the international application required under 35 U.S.C.
                           					<b><a href="mpep-0010-title-page.html#d0e303023">120</a></b> and <b><a href="mpep-9015-appx-l.html#d0e307034">365</a></b> (c) must either be contained in the first sentence(s) of
                           				the specification following the title or included in an application data sheet. 37
                           				CFR <b><a href="mpep-9020-appx-r.html#d0e320662">1.78</a></b> (a)(2)(iii). The specific
                           				reference must identify the parent international application by international
                           				application number and international filing date and indicate the relationship of
                           				the applications (i.e., continuation, continuation-in-part, or division). See 37 CFR
                           					<b><a href="mpep-9020-appx-r.html#d0e320662">1.78</a></b> (a)(2)(i)) and MPEP § 
                           					<b><a href="mpep-0010-title-page.html#d0e10254">201.11</a></b> . An example of an appropriate first sentence of
                           				the specification is, for example, “This is a continuation of International
                           				Application PCT/EP2004/000000, with an international filing date of January 5, 2004,
                           				now abandoned.” The required reference must be submitted within the time period
                           				provided by 37 CFR <b><a href="mpep-9020-appx-r.html#d0e320662">1.78</a></b> (a)( 2 )(ii). This time
                           				period is not extendable. A certified copy of the international application (and an
                           				English translation) of the international application may be required by the
                           				examiner to perfect the claim for benefit under 35 U.S.C. <b><a href="mpep-0010-title-page.html#d0e303023">120</a></b> and <b><a href="mpep-9015-appx-l.html#d0e307034">365</a></b> (c) if the international
                           				application did not originate in the United States and such is necessary, for
                           				example, where an intervening reference is found and applied in a rejection of one
                           				or more claims. If the international application was published by the International
                           				Bureau pursuant to PCT Article <b><a href="mpep-9025-appx-t.html#d0e363622">21</a></b> , then a certified copy
                           				would not normally be necessary. 
                        </p>
                        <p id="d0e192877"> If benefit under 35 U.S.C.
                           					<b><a href="mpep-9015-appx-l.html#d0e302921">119</a></b> (e), <b><a href="mpep-0010-title-page.html#d0e303023"> and/or under
                                 					35 U.S.C. 120 </a></b> and <b><a href="mpep-9015-appx-l.html#d0e307034">365</a></b> (c) is
                           				being claimed to an earlier filed national application (or international application
                           				designating the U.S.) via an intermediate international application designating the
                           				U.S., then the intermediate international application must contain a specific
                           				reference to the earlier application, as required under 37 CFR <b><a href="mpep-9020-appx-r.html#d0e320662">1.78</a></b> . The specific reference will usually be included on
                           				the cover page of the published international application and/or may appear in the
                           				first sentence(s) of the description of the published application. A lack of a
                           				proper reference in the published international application does not necessarily
                           				mean that a proper reference is not contained in the intermediate international
                           				application. Accordingly, the international application file (if the USPTO was the
                           				receiving Office) may have to be inspected to determine whether the requirements
                           				under 37 CFR <b><a href="mpep-9020-appx-r.html#d0e320662">1.78</a></b> (a) were satisfied after
                           				publication of the international application . For example, the intermediate
                           				international application file may contain the specific reference in a separate
                           				paper filed after publication but during the pendency of the international
                           				application, or a decision granting a petition to accept a late benefit claim may be
                           				present in the application file. See MPEP § <b><a href="mpep-0010-title-page.html#d0e12704">201.11(a)</a></b> . The
                           				examiner may contact the Office of PCT Legal Administration for assistance. 
                        </p>
                        <p id="d0e192936"> With regard to (B), a U.S.
                           				national application is considered copending with a prior international application
                           				designating the U.S. if the international application was pending on the filing date
                           				of the U.S. national application. Generally, except in cases where the international
                           				application has been withdrawn (either generally or as to the United States), an
                           				international application becomes abandoned as to the United States upon expiration
                           				of 30 months from the priority date (i.e., the priority date claimed in the
                           				international application or, if no priority is claimed, the international filing
                           				date) unless a proper submission under <b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C. 371</a></b>
                           				to enter the U.S. national phase is filed prior to the expiration of this 30-month
                           				period. See MPEP § <b><a href="s1893.html#d0e190008">1893.01</a></b> (a)(1) and §
                           					<b><a href="s1893.html#d0e191079">1893.02</a></b> . However, if the international application is
                           				one where the 20-month period from the priority date expired before April 1, 2002,
                           				then it was necessary to file a demand electing the United States prior to the
                           				expiration of 19 months from the priority date in order to extend the international
                           				phase to 30 months from the priority date. If such a demand was not timely filed,
                           				then under former 37 CFR <b><a href="mpep-9020-appx-r.html#d0e329457">1.494</a></b> , such an international
                           				application became abandoned at the expiration of 20 months from the priority date
                           				unless a proper submission under 35 U.S.C. 371 to enter the U.S. national phase was
                           				made prior to the expiration of 20 months from the priority date. Accordingly, if
                           				the international application is not subject to the filing of a demand in order to
                           				delay entry into the U.S. national phase to 30 months from the priority date, then a
                           				national application filed prior to the expiration of this 30 month period will be
                           				copending with the international application unless the international application
                           				was withdrawn, either generally or as to the United States, prior to the filing of
                           				the national application. To determine whether the application was withdrawn, the
                           				examiner must either review the Home Copy of the international application file (if
                           				the USPTO was the receiving Office), or require applicant to certify that the
                           				international application was not withdrawn or considered to be withdrawn, either
                           				generally or as to the United States, prior to the filing date of the national
                           				application claiming benefit under 35 U.S.C. <b><a href="mpep-0010-title-page.html#d0e303023">120</a></b> and
                           					<b><a href="mpep-9015-appx-l.html#d0e307034">365</a></b> (c) to such international
                           				application. In order to expedite examination, applicant should certify at the time
                           				of filing a national application claiming benefit under 35 U.S.C. <b><a href="mpep-0010-title-page.html#d0e303023">120</a></b> and <b><a href="mpep-9015-appx-l.html#d0e307034">365</a></b> (c) to an international
                           				application that the international application has not been withdrawn. If the
                           				national application claiming benefit to the international application was filed
                           				after the expiration of this 30-month period, then there will be no copendency in
                           				the absence of a timely and proper submission to enter the U.S. national phase under
                           					<b><a href="mpep-9015-appx-l.html#d0e307164">35 U.S.C. 371</a></b> . The existence
                           				of a national stage application may be checked through PALM and the records of the
                           				national stage application should be consulted to verify copendency. Additionally,
                           				if the 20-month period from the priority date of the international application
                           				expired before April 1, 2002 and the national application claiming benefit under 35
                           				U.S.C. <b><a href="mpep-0010-title-page.html#d0e303023">120</a></b> and <b><a href="mpep-9015-appx-l.html#d0e307034">365</a></b> (c) was filed later than 20 months from the priority
                           				date of the international application, the applicant may be required to submit proof
                           				of the filing of a demand electing the United States within 19 months from the
                           				priority date. This proof may be in the form of a copy of the “Notification of
                           				Receipt of Demand by Competent International Preliminary Examining Authority” (Form
                           				PCT/IPEA/402) showing the demand was received prior to the expiration of 19 months
                           				from the priority date, and a copy of the “Notification Concerning Elected Offices
                           				Notified of Their Election” (Form PCT/IB/332) showing the election of the United
                           				States. If the parent international application was not copending (i.e., abandoned
                           				or withdrawn), benefit under 35 U.S.C. <b><a href="mpep-0010-title-page.html#d0e303023">120</a></b> is not
                           				possible. 
                        </p>
                        <p id="d0e192979"> With regard to (C), inventors
                           				will normally be identified on the cover page of the published international
                           				application. In addition, such information is indicated in the <i>PCT Gazette</i> , which is available in electronic form
                           				from WIPO’s web site (www.wipo.int/pct/en/index.html). 
                        </p>
                        <div class="Section">
                           <h2 class="section1" id="d0e192985">
                                 PRIORITY CLAIMS UNDER 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e302921">119</a></b> (a)-(d) 
                           </h2>
                           <p id="d0e192992"> A claim for foreign priority
                              					under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e302921">119</a></b> (a)-(d) must be made in
                              					the continuing application in order to obtain the benefit of the filing date of
                              					the prior filed foreign application. This is true regardless of whether such a
                              					claim was made in the parent international application. A foreign priority claim
                              					is proper in the continuing application if the foreign application was filed
                              					within 12 months prior to the filing of the continuing application or within 12
                              					months prior to the international filing date of the parent international
                              					application. In addition, the required claim must be made within the time period
                              					set forth in 37 CFR <b><a href="mpep-9020-appx-r.html#d0e319215">1.55</a></b> (a)(1). This time
                              					period is not extendable. See MPEP § <b><a href="mpep-0010-title-page.html#d0e14253">201.14</a></b> . A
                              					certified copy of any foreign priority document must be provided by the
                              					applicant or furnished in accordance with 37 CFR <b><a href="mpep-9020-appx-r.html#d0e319215">1.55</a></b> (d) unless the parent international application has
                              					entered the national stage under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e307164">371</a></b> and
                              					the national stage application contains a photocopy of the priority document
                              					from the International Bureau. See MPEP §  <b><a href="s1893.html#d0e191506">1893.03(c)</a></b> . In such case, the applicant, in the
                              					continuing application, may state that the priority document is contained in the
                              					national stage application. 
                           </p>
                           <p id="d0e193017"> For a discussion of U.S.
                              					national applications filed under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e302673">111</a></b> (a)
                              					having foreign priority claims under 35 U.S.C. <b><a href="mpep-9015-appx-l.html#d0e302921">119</a></b> (a)-(d) and <b><a href="mpep-9015-appx-l.html#d0e307034">365</a></b> (a) to
                              					a prior international application designating at least one country other than
                              					the United States, see MPEP § <b><a href="mpep-0010-title-page.html#d0e13987">201.13(b)</a></b> .
                              				
                           </p>
                        </div>
                     </div>
                     <p align="right"><a href="#top">[top]</a></p>
                  </div>
               </div>
               <div>
                  <h1 class="page-title"> </h1>
               </div>  </div>
            </div>
         </div>
      </div>
      <div class="yui-b">
         <div id="aside">  <div id="rdms-sub-nav-container" xmlns:bf="http://www.uspto.gov/bf">
            <ul id="sub-nav">
               <li xmlns=""><a href="s1801.html">1801-Basic Patent Cooperation Treaty (PCT) Principles</a></li>
               <li xmlns=""><a href="s1802.html">1802-PCT Definitions</a></li>
               <li xmlns=""><a href="s1803.html">1803-Reservations Under the PCT Taken by the United States of America</a></li>
               <li xmlns=""><a href="s1804.html">1804-[Reserved]</a></li>
               <li xmlns=""><a href="s1805.html">1805-Where To File an International Application</a></li>
               <li xmlns=""><a href="s1806.html">1806-[Reserved]</a></li>
               <li xmlns=""><a href="s1807.html">1807-Agent or Common Representative and General Power of Attorney</a></li>
               <li xmlns=""><a href="s1808.html">1808-Change in or Revocation of the Appointment of an Agent or a Common Representative</a></li>
               <li xmlns=""><a href="s1809.html">1809-[Reserved]</a></li>
               <li xmlns=""><a href="s1810.html">1810-Filing Date Requirements</a></li>
               <li xmlns=""><a href="s1811.html">1811-[Reserved]</a></li>
               <li xmlns=""><a href="s1812.html">1812-Elements of the International Application</a></li>
               <li xmlns=""><a href="s1813 - 1816.html">1813 - 1816-[Reserved]</a></li>
               <li xmlns=""><a href="s1817.html">1817-PCT Member States</a><ul>
                     <li><a href="s1817.html#d0e167497">1817.01-Designation of States in International Applications Having an International Filing Date On or After January 1, 2004</a><ul style="list-style-type: none">
                           <li><a href="s1817.html#d0e167644">1817.01(a)-Designation of States and Precautionary Designations in International Applications Having an International Filing Date Before
                                 January 1, 2004</a></li>
                        </ul>
                     </li>
                     <li><a href="s1817.html#d0e167827">1817.02-Continuation or Continuation-in-Part Indication in the Request</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1818.html">1818-[Reserved]</a></li>
               <li xmlns=""><a href="s1819.html">1819-Earlier Search</a></li>
               <li xmlns=""><a href="s1820.html">1820-Signature of Applicant</a></li>
               <li xmlns=""><a href="s1821.html">1821-The Request</a></li>
               <li xmlns=""><a href="s1822.html">1822-[Reserved]</a></li>
               <li xmlns=""><a href="s1823.html">1823-The Description</a><ul>
                     <li><a href="s1823.html#d0e168618">1823.01-Reference to Deposited Biological Material</a></li>
                     <li><a href="s1823.html#d0e169024">1823.02-Nucleotide and/or Amino Acid Sequence Listings, and Tables Related to Sequence Listings</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1824.html">1824-The Claims</a></li>
               <li xmlns=""><a href="s1825.html">1825-The Drawings</a></li>
               <li xmlns=""><a href="s1826.html">1826-The Abstract</a></li>
               <li xmlns=""><a href="s1827.html">1827-Fees</a><ul>
                     <li><a href="s1827.html#d0e170417">1827.01-Refund of International Application Fees</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1828.html">1828-Priority Claim and Document</a><ul>
                     <li><a href="s1828.html#d0e170589">1828.01-Restoration of the Right of Priority</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1829.html">1829-[Reserved]</a></li>
               <li xmlns=""><a href="s1830.html">1830-International Application Transmittal Letter</a></li>
               <li xmlns=""><a href="s1831.html">1831-[Reserved]</a></li>
               <li xmlns=""><a href="s1832.html">1832-License Request for Foreign Filing Under the PCT</a></li>
               <li xmlns=""><a href="s1833.html">1833-[Reserved]</a></li>
               <li xmlns=""><a href="s1834.html">1834-Correspondence</a><ul>
                     <li><a href="s1834.html#d0e170909">1834.01-Use of Telegraph, Teleprinter, Facsimile Machine</a></li>
                     <li><a href="s1834.html#d0e170997">1834.02-Irregularities in the Mail Service</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1835.html">1835-[Reserved]</a></li>
               <li xmlns=""><a href="s1836.html">1836-Rectification of Obvious Mistakes</a></li>
               <li xmlns=""><a href="s1837-1839.html">1837-1839-[Reserved]</a></li>
               <li xmlns=""><a href="s1840.html">1840-The International Searching Authority</a><ul>
                     <li><a href="s1840.html#d0e171588">1840.01-The European Patent Office as an International Searching Authority</a></li>
                     <li><a href="s1840.html#d0e171975">1840.02-The Korean Intellectual Property Office as an International Searching Authority</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1841.html">1841-[Reserved]</a></li>
               <li xmlns=""><a href="s1842.html">1842-Basic Flow Under the PCT</a></li>
               <li xmlns=""><a href="s1843.html">1843-The International Search</a><ul>
                     <li><a href="s1843.html#d0e172347">1843.01-Prior Art for Chapter I Processing</a></li>
                     <li><a href="s1843.html#d0e172603">1843.02-Certain Subject Matter Need Not Be Searched</a></li>
                     <li><a href="s1843.html#d0e172803">1843.03-No Search Required if Claims Are Unclear</a></li>
                     <li><a href="s1843.html#d0e172835">1843.04-Procedure for Claims Not Required To Be Searched and for Claims That Are Unclear</a></li>
                     <li><a href="s1843.html#d0e172870">1843.05-Time Limit for Establishing the International Search Report and the Written Opinion of the International Searching Authority</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1844.html">1844-The International Search Report</a><ul>
                     <li><a href="s1844.html#d0e172999">1844.01-Preparing the International Search Report (Form PCT/ISA/210)</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1845.html">1845-Written Opinion of the International Searching Authority</a><ul>
                     <li><a href="s1845.html#d0e173906">1845.01-Preparing the Written Opinion of the International Searching Authority (Form PCT/ISA/237)</a></li>
                     <li><a href="s1845.html#d0e174931">1845.02-Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority,
                           or the Declaration (Form PCT/ISA/220)</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1846.html">1846-Sections of the Articles, Regulations, and Administrative Instructions Under the PCT Relevant to the International Searching
                     Authority</a></li>
               <li xmlns=""><a href="s1847.html">1847-[Reserved]</a></li>
               <li xmlns=""><a href="s1848.html">1848-Sequence Listings and Tables Related to Sequence Listings</a></li>
               <li xmlns=""><a href="s1849.html">1849-[Reserved]</a></li>
               <li xmlns=""><a href="s1850.html">1850-Unity of Invention Before the International Searching Authority</a></li>
               <li xmlns=""><a href="s1851.html">1851-Identification of Patent Documents</a></li>
               <li xmlns=""><a href="s1852.html">1852-Taking Into Account Results of Earlier Search(es)</a></li>
               <li xmlns=""><a href="s1853.html">1853-Amendment Under PCT Article 19</a></li>
               <li xmlns=""><a href="s1854-1856.html">1854-1856-[Reserved]</a></li>
               <li xmlns=""><a href="s1857.html">1857-International Publication</a><ul>
                     <li><a href="s1857.html#d0e182117">1857.01-Prior Art Effect of the International Publication</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1858.html">1858-[Reserved]</a></li>
               <li xmlns=""><a href="s1859.html">1859-Withdrawal of International Application, Designations, or Priority Claims</a></li>
               <li xmlns=""><a href="s1860.html">1860-International Preliminary Examination Procedure for Applications Having an International Filing Date On or After January 1,
                     2004</a><ul>
                     <li><a href="s1860.html#d0e182787">1860.01-International Preliminary Examination Procedure for Applications Having an International Filing Date Before January 1, 2004</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1861.html">1861-[Reserved]</a></li>
               <li xmlns=""><a href="s1862.html">1862-Agreement With the International Bureau To Serve as an International Preliminary Examining Authority</a></li>
               <li xmlns=""><a href="s1863.html">1863-[Reserved]</a></li>
               <li xmlns=""><a href="s1864.html">1864-The Demand and Preparation for Filing of Demand</a><ul>
                     <li><a href="s1864.html#d0e183157">1864.01-Amendments Filed Under PCT Article 34</a></li>
                     <li><a href="s1864.html#d0e183297">1864.02-Applicant’s Right To File a Demand</a></li>
                     <li><a href="s1864.html#d0e183417">1864.03-States Which May Be Elected</a></li>
                     <li><a href="s1864.html#d0e183461">1864.04-Agent’s Right To Act</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1865.html">1865-Filing of Demand</a><ul>
                     <li><a href="s1865.html#d0e183713">1865.01-The European Patent Office as an International Preliminary Examining Authority</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1866.html">1866-Filling in of Headings on Chapter II Forms</a></li>
               <li xmlns=""><a href="s1867.html">1867-Preliminary Examination Fees</a></li>
               <li xmlns=""><a href="s1868.html">1868-Correction of Defects in the Demand</a></li>
               <li xmlns=""><a href="s1869.html">1869-Notification to International Bureau of Demand</a></li>
               <li xmlns=""><a href="s1870.html">1870-Priority Document and Translation Thereof</a></li>
               <li xmlns=""><a href="s1871.html">1871-Processing Amendments Filed Under Article 19 and Article 34 Prior to or at the Start of International Preliminary Examination
                     in International Applications Having an International Filing Date On or After January 1, 2004</a><ul>
                     <li><a href="s1871.html#d0e184948">1871.01-Processing Amendments Filed Under Article 19 and Article 34 Prior to or at the Start of International Preliminary Examination
                           in International Applications Having an International Filing Date Before January 1, 2004</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1872.html">1872-Availability of the International Application File for International Preliminary Examination by the Examining Corps</a></li>
               <li xmlns=""><a href="s1873.html">1873-[Reserved]</a></li>
               <li xmlns=""><a href="s1874.html">1874-Determination if International Preliminary Examination Is Required and Possible</a></li>
               <li xmlns=""><a href="s1875.html">1875-Unity of Invention Before the International Preliminary Examining Authority</a><ul>
                     <li><a href="s1875.html#d0e185391">1875.01-Preparation of Invitation Concerning Unity</a></li>
                     <li><a href="s1875.html#d0e185503">1875.02-Reply to Invitation Concerning Lack of Unity of Invention</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1876.html">1876-Notation of Errors and Informalities by the Examiner</a><ul>
                     <li><a href="s1876.html#d0e185657">1876.01-Request for Rectification and Notification of Action Thereon</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1877.html">1877-Nucleotide and/or Amino Acid Sequence Listings During the International Preliminary Examination</a></li>
               <li xmlns=""><a href="s1878.html">1878-Preparation of the Written Opinion of the International Preliminary Examining Authority in International Applications Having
                     an International Filing Date On or After January 1, 2004</a><ul>
                     <li><a href="s1878.html#d0e186282">1878.01-Preparation of the Written Opinion in International Applications Having an International Filing Date Before January 1, 2004</a><ul style="list-style-type: none">
                           <li><a href="s1878.html#d0e187509">1878.01(a)-Prior Art for Purposes of the Written Opinion and the International Preliminary Examination Report</a><ul>
                                 <li><a href="s1878.html#d0e187677">1878.01(a)(1)-Novelty for Purposes of the Written Opinion and the International Preliminary Examination Report</a></li>
                                 <li><a href="s1878.html#d0e187723">1878.01(a)(2)-Inventive Step for Purposes of the Written Opinion and the International Preliminary Examination Report</a></li>
                                 <li><a href="s1878.html#d0e187807">1878.01(a)(3)-Industrial Applicability for Purposes of the Written Opinion and the International Preliminary Examination Report</a></li>
                              </ul>
                           </li>
                        </ul>
                     </li>
                     <li><a href="s1878.html#d0e187853">1878.02-Reply to the Written Opinion of the ISA or IPEA</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1879.html">1879-Preparation of the International Preliminary Examination Report</a><ul>
                     <li><a href="s1879.html#d0e188619">1879.01-Time Limit for Preparing Report in International Applications Having an International Filing Date On or After January 1, 2004</a><ul style="list-style-type: none">
                           <li><a href="s1879.html#d0e188804">1879.01(a)-Time Limit for Preparing Report in International Application Having an International Filing Date Before January 1, 2004</a></li>
                        </ul>
                     </li>
                     <li><a href="s1879.html#d0e188956">1879.02-Transmittal of the International Preliminary Examination Report</a></li>
                     <li><a href="s1879.html#d0e189042">1879.03-Translations</a></li>
                     <li><a href="s1879.html#d0e189228">1879.04-Confidential Nature of the Report</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1880.html">1880-Withdrawal of Demand or Election</a></li>
               <li xmlns=""><a href="s1881.html">1881-Receipt of Notice of Election and Preliminary Examination Report by the United States Patent and Trademark Office</a></li>
               <li xmlns=""><a href="s1882-1892.html">1882-1892-[Reserved]</a></li>
               <li xmlns=""><a href="s1893.html">1893-National Stage (U.S. National Application Filed Under 35 U.S.C. 371)</a><ul>
                     <li><a href="s1893.html#d0e189843">1893.01-Commencement and Entry</a><ul style="list-style-type: none">
                           <li><a href="s1893.html#d0e190008">1893.01(a)-Entry via the U.S. Designated or Elected Office</a><ul>
                                 <li><a href="s1893.html#d0e190240">1893.01(a)(1)-Submissions Required by 30 Months from the Priority Date</a></li>
                                 <li><a href="s1893.html#d0e190345">1893.01(a)(2)-Article 19 Amendment (Filed With the International Bureau)</a></li>
                                 <li><a href="s1893.html#d0e190402">1893.01(a)(3)-Article 34 Amendments (Filed with the International Preliminary Examining Authority)</a></li>
                              </ul>
                           </li>
                           <li><a href="s1893.html#d0e190492">1893.01(c)-Fees</a></li>
                           <li><a href="s1893.html#d0e190635">1893.01(d)-Translation</a></li>
                           <li><a href="s1893.html#d0e190737">1893.01(e)-Oath/Declaration</a></li>
                        </ul>
                     </li>
                     <li><a href="s1893.html#d0e191079">1893.02-Abandonment</a></li>
                     <li><a href="s1893.html#d0e191121">1893.03-Prosecution of U.S. National Stage Applications Before the Examiner</a><ul style="list-style-type: none">
                           <li><a href="s1893.html#d0e191193">1893.03(a)-How To Identify That an Application Is a U.S. National Stage Application</a></li>
                           <li><a href="s1893.html#d0e191308">1893.03(b)-The Filing Date of a U.S. National Stage Application</a></li>
                           <li><a href="s1893.html#d0e191506">1893.03(c)-The Priority Date, Priority Claim, and Priority Papers for a U.S. National Stage Application</a></li>
                           <li><a href="s1893.html#d0e191885">1893.03(d)-Unity of Invention</a></li>
                           <li><a href="s1893.html#d0e192440">1893.03(e)-Documents Received from the International Bureau and Placed in a U.S. National Stage Application File</a><ul>
                                 <li><a href="s1893.html#d0e192601">1893.03(e)(1)-Title of the Invention</a></li>
                              </ul>
                           </li>
                           <li><a href="s1893.html#d0e192624">1893.03(f)-Drawings and PCT Rule 11</a></li>
                           <li><a href="s1893.html#d0e192639">1893.03(g)-Information Disclosure Statement in a National Stage Application</a></li>
                        </ul>
                     </li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1894.html">1894-[Reserved]</a></li>
               <li xmlns=""><a href="s1895.html">1895-A Continuation , Divisional, or Continuation- in- Part Application of a PCT Application Designating the United States</a><ul>
                     <li><a href="s1895.html#d0e192774">1895.01-Handling of and Considerations in the Handling of Continuations, Divisions, and Continuations-In-Part of PCT Applications</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1896.html">1896-The Differences Between a National Application Filed Under 35 U.S.C. 111(a) and a National Stage Application Submitted Under
                     35 U.S.C. 371</a></li>
            </ul>  </div>
         </div>
      </div>  </div>
      

  <div style="text-align:right"> Last Modified: 

     

    03/27/2014 10:10:33 

  </div>

</div>

</div>




<!-- End of footer2.html -->


   </body>
</html>